Wound Debridement Market Size, Share, Growth, Trends | Report 2023-2032
The global wound debridement market size was estimated at around USD 4.50 billion in 2022 and it is projected to hit around USD 8.26 billion by 2032, growing at a CAGR of 6.26% from 2023 to 2032.
Key Pointers
| Report Coverage | Details |
| Market Size in 2022 | USD 4.50 billion |
| Revenue Forecast by 2032 | USD 8.26 billion |
| Growth rate from 2023 to 2032 | CAGR of 6.26% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Coloplast Corp.; Medline Industries; Smith & Nephew; ConvaTec Group PLC; Integra LifeSciences; Molnlycke Health Care AB, B. Braun SE; Brightwake Ltd., Lohmann & Rauscher; 3M |
The high incidence of chronic conditions, such as pressure ulcers, diabetic foot ulcers, and other target wounds, the availability of reimbursement in developed economies, and changing lifestyles are anticipated to drive the market. Furthermore, the increased incidences of injuries such as accidents as road accidents, burns, and trauma events across the globe are also anticipated to drive the market. Additionally, the widening base of the geriatric population and increasing initiatives by governments and private organizations to raise awareness regarding wound care treatment are projected to work in favor of the market.
An increased number of people suffer from diabetes globally. This is anticipated to further impel the market growth. According to the International Diabetes Federation, diabetes is one of the most prevalent medical disorders in the world, affecting almost 537 million adults in 2021. It is expected to affect 643 million people by 2030 and 783 million people by 2045. In Europe, 19.3 million persons between the ages of 60 and 79, 11.3 million between the ages of 40 and 59, and 1.7 million between the ages of 20 and 39 had diabetes, in 2019.
The biggest percentage of diabetics (10.5%) in Europe was in Germany, followed by Portugal (9.5%) and Cyprus (9.0%). Such a high number of diabetics increase the risk of diabetic foot ulcers, and other wounds, which are difficult to treat & take longer duration to heal. These wounds require advanced wound debridement products, and thus the wound debridement industry is expected to grow over the forecast period.
Furthermore, tragic accidents have occurred more frequently worldwide. For instance, according to estimates provided by the WHO, vehicle accidents cause about 1.2 million fatalities each year while 20 to 50 million people suffer non-fatal injuries. Similarly, according to Economic Times, India witnessed 5,54,796 road accidents in 2020. These mishaps frequently cause serious bleeding and other injuries, prompting quick medical attention and occasionally requiring surgical operations to provide patients with immediate relief. As wound debridement products help in the debridement of such accidental wounds, the demand for wound debridement is expected to expand significantly over the forecast period.
Wound Debridement Market Segmentations:
| By Product | By Method | By Wound Type | By End-use | By Mode of Purchase |
|
Gels Ointments & Creams Surgical Devices Medical Gauzes Ultrasonic Devices Others |
Autolytic Enzymatic Surgical Mechanical Others |
Pressure Ulcers Diabetic Foot Ulcers Venous Leg Ulcers Burn Wounds Others |
Hospitals Homecare Others |
Prescription Over The Counter Others |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Wound Debridement Market
5.1. COVID-19 Landscape: Wound Debridement Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Wound Debridement Market, By Product
8.1. Wound Debridement Market, by Product, 2023-2032
8.1.1. Gels
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Ointments & Creams
8.1.2.1. Market Revenue and Forecast (2019-2032)
8.1.3. Surgical Devices
8.1.3.1. Market Revenue and Forecast (2019-2032)
8.1.4. Medical Gauzes
8.1.4.1. Market Revenue and Forecast (2019-2032)
8.1.5. Ultrasonic Devices
8.1.5.1. Market Revenue and Forecast (2019-2032)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Wound Debridement Market, By Method
9.1. Wound Debridement Market, by Method, 2023-2032
9.1.1. Autolytic
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Enzymatic
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Surgical
9.1.3.1. Market Revenue and Forecast (2019-2032)
9.1.4. Mechanical
9.1.4.1. Market Revenue and Forecast (2019-2032)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Wound Debridement Market, By Wound Type
10.1. Wound Debridement Market, by Wound Type, 2023-2032
10.1.1. Pressure Ulcers
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Diabetic Foot Ulcers
10.1.2.1. Market Revenue and Forecast (2019-2032)
10.1.3. Venous Leg Ulcers
10.1.3.1. Market Revenue and Forecast (2019-2032)
10.1.4. Burn Wounds
10.1.4.1. Market Revenue and Forecast (2019-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global Wound Debridement Market, By End-use
11.1. Wound Debridement Market, by End-use, 2023-2032
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast (2019-2032)
11.1.2. Homecare
11.1.2.1. Market Revenue and Forecast (2019-2032)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 12. Global Wound Debridement Market, By Mode of Purchase
12.1. Wound Debridement Market, by Mode of Purchase, 2023-2032
12.1.1. Prescription
12.1.1.1. Market Revenue and Forecast (2019-2032)
12.1.2. Over The Counter
12.1.2.1. Market Revenue and Forecast (2019-2032)
12.1.3. Others
12.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 13. Global Wound Debridement Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2019-2032)
13.1.2. Market Revenue and Forecast, by Method (2019-2032)
13.1.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.1.4. Market Revenue and Forecast, by End-use (2019-2032)
13.1.5. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2019-2032)
13.1.6.2. Market Revenue and Forecast, by Method (2019-2032)
13.1.6.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.1.6.4. Market Revenue and Forecast, by End-use (2019-2032)
13.1.7. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Product (2019-2032)
13.1.8.2. Market Revenue and Forecast, by Method (2019-2032)
13.1.8.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.1.8.4. Market Revenue and Forecast, by End-use (2019-2032)
13.1.8.5. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2019-2032)
13.2.2. Market Revenue and Forecast, by Method (2019-2032)
13.2.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.2.4. Market Revenue and Forecast, by End-use (2019-2032)
13.2.5. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2019-2032)
13.2.6.2. Market Revenue and Forecast, by Method (2019-2032)
13.2.6.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.2.7. Market Revenue and Forecast, by End-use (2019-2032)
13.2.8. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2019-2032)
13.2.9.2. Market Revenue and Forecast, by Method (2019-2032)
13.2.9.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.2.10. Market Revenue and Forecast, by End-use (2019-2032)
13.2.11. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2019-2032)
13.2.12.2. Market Revenue and Forecast, by Method (2019-2032)
13.2.12.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.2.12.4. Market Revenue and Forecast, by End-use (2019-2032)
13.2.13. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2019-2032)
13.2.14.2. Market Revenue and Forecast, by Method (2019-2032)
13.2.14.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.2.14.4. Market Revenue and Forecast, by End-use (2019-2032)
13.2.15. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2019-2032)
13.3.2. Market Revenue and Forecast, by Method (2019-2032)
13.3.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.3.4. Market Revenue and Forecast, by End-use (2019-2032)
13.3.5. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2019-2032)
13.3.6.2. Market Revenue and Forecast, by Method (2019-2032)
13.3.6.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.3.6.4. Market Revenue and Forecast, by End-use (2019-2032)
13.3.7. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2019-2032)
13.3.8.2. Market Revenue and Forecast, by Method (2019-2032)
13.3.8.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.3.8.4. Market Revenue and Forecast, by End-use (2019-2032)
13.3.9. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2019-2032)
13.3.10.2. Market Revenue and Forecast, by Method (2019-2032)
13.3.10.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.3.10.4. Market Revenue and Forecast, by End-use (2019-2032)
13.3.10.5. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2019-2032)
13.3.11.2. Market Revenue and Forecast, by Method (2019-2032)
13.3.11.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.3.11.4. Market Revenue and Forecast, by End-use (2019-2032)
13.3.11.5. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2019-2032)
13.4.2. Market Revenue and Forecast, by Method (2019-2032)
13.4.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.4.4. Market Revenue and Forecast, by End-use (2019-2032)
13.4.5. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2019-2032)
13.4.6.2. Market Revenue and Forecast, by Method (2019-2032)
13.4.6.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.4.6.4. Market Revenue and Forecast, by End-use (2019-2032)
13.4.7. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2019-2032)
13.4.8.2. Market Revenue and Forecast, by Method (2019-2032)
13.4.8.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.4.8.4. Market Revenue and Forecast, by End-use (2019-2032)
13.4.9. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2019-2032)
13.4.10.2. Market Revenue and Forecast, by Method (2019-2032)
13.4.10.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.4.10.4. Market Revenue and Forecast, by End-use (2019-2032)
13.4.10.5. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2019-2032)
13.4.11.2. Market Revenue and Forecast, by Method (2019-2032)
13.4.11.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.4.11.4. Market Revenue and Forecast, by End-use (2019-2032)
13.4.11.5. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2019-2032)
13.5.2. Market Revenue and Forecast, by Method (2019-2032)
13.5.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.5.4. Market Revenue and Forecast, by End-use (2019-2032)
13.5.5. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2019-2032)
13.5.6.2. Market Revenue and Forecast, by Method (2019-2032)
13.5.6.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.5.6.4. Market Revenue and Forecast, by End-use (2019-2032)
13.5.7. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2019-2032)
13.5.8.2. Market Revenue and Forecast, by Method (2019-2032)
13.5.8.3. Market Revenue and Forecast, by Wound Type (2019-2032)
13.5.8.4. Market Revenue and Forecast, by End-use (2019-2032)
13.5.8.5. Market Revenue and Forecast, by Mode of Purchase (2019-2032)
Chapter 14. Company Profiles
14.1. Coloplast Corp.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Medline Industries
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Smith & Nephew
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. ConvaTec Group PLC
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Integra LifeSciences
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Molnlycke Health Care AB
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. B. Braun SE
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Brightwake Ltd.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Lohmann & Rauscher
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. 3M
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers